- Corporate Officers - B
- Bertolini Robert J
Insider Trading History of Bertolini Robert J
The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) by Bertolini Robert J since 2006.
The trader's CIK number is 1270263.
At the time of the last reporting, Bertolini Robert J was the Executive Vice Presi of Charles River Laboratories International, Inc.. (stock ticker symbol CRL).
Also see all insider trading activities at Charles River Laboratories International, Inc..
Note that in the past
BERTOLINI ROBERT J also reported insider trading activities as an insider of the following companies:
Yearly summary of insider trading at Genzyme Corp (GENZ) by Bertolini Robert J
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2011 | GENZ | 0 | $0 | 0 | $0 | 2,375 | $0 |
| 2010 | GENZ | 0 | $0 | 0 | $0 | 2,375 | $0 |
Yearly summary of insider trading at Bristol Myers Squibb Co (BMY) by Bertolini Robert J
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2019 | BMY | 11,000 | $491,920 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Charles River Laboratories International, Inc. (CRL) by Bertolini Robert J
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2020 | CRL | 0 | $0 | 10,700 | $1,838,081 | 10,700 | $592,125 |
| 2018 | CRL | 0 | $0 | 12,280 | $1,459,216 | 12,280 | $465,731 |
| 2017 | CRL | 0 | $0 | 11,990 | $1,052,809 | 11,990 | $453,341 |
Yearly summary of insider trading at Merck & Co., Inc. (SGP) by Bertolini Robert J
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2009 | SGP | 0 | $0 | 0 | $0 | 40,000 | $0 |
| 2008 | SGP | 0 | $0 | 0 | $0 | 45,000 | $0 |
| 2006 | SGP | 0 | $0 | 0 | $0 | 110,000 | $0 |
Insider trading activities at 4 companies by Bertolini Robert J:
1. Genzyme Corp (GENZ)
2. Bristol Myers Squibb Co (BMY)
3. Charles River Laboratories International, Inc. (CRL)
4. Merck & Co., Inc. (SGP)
Table 1. Insider trading of Genzyme Corp (GENZ) by Bertolini Robert J
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2011-04-04 | GENZ | Option Ex | 2,375 | .00 | 0 |
| 2010-06-16 | GENZ | Option Ex | 2,375 | .00 | 0 |
Table 2. Insider trading of Bristol Myers Squibb Co (BMY) by Bertolini Robert J
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2019-07-31 | BMY | Buy | 11,000 | 44.72 | 491,920 |
Table 3. Insider trading of Charles River Laboratories International, Inc. (CRL) by Bertolini Robert J
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2020-05-20 | CRL | Option Ex | 3,530 | 52.29 | 184,583 |
| 2020-05-20 | CRL | Sale | 3,530 | 174.58 | 616,263 |
| 2020-02-13 | CRL | Option Ex | 7,170 | 56.84 | 407,542 |
| 2020-02-13 | CRL | Sale | 7,170 | 170.41 | 1,221,818 |
| 2018-12-04 | CRL | Sale | 1,100 | 134.73 | 148,203 |
| 2018-12-04 | CRL | Sale | 3,440 | 133.82 | 460,344 |
| 2018-12-04 | CRL | Option Ex | 4,540 | 33.93 | 154,042 |
| 2018-01-02 | CRL | Sale | 3,609 | 110.27 | 397,957 |
| 2018-01-02 | CRL | Option Ex | 7,740 | 40.27 | 311,689 |
| 2018-01-02 | CRL | Sale | 4,131 | 109.59 | 452,712 |
| 2017-03-01 | CRL | Option Ex | 11,990 | 37.81 | 453,341 |
| 2017-03-01 | CRL | Sale | 5,255 | 87.50 | 459,833 |
| 2017-03-01 | CRL | Sale | 6,735 | 88.04 | 592,976 |
Table 4. Insider trading of Merck & Co., Inc. (SGP) by Bertolini Robert J
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2009-04-01 | SGP | Option Ex | 40,000 | .00 | 0 |
| 2008-04-25 | SGP | Option Ex | 45,000 | .00 | 0 |
| 2006-12-01 | SGP | Option Ex | 45,000 | .00 | 0 |
| 2006-11-17 | SGP | Option Ex | 65,000 | .00 | 0 |
Insider trading activities including stock purchases, stock sales, and option exercises
listed in the above table cannot be completely guaranteed as to their accuracy.
For more information regarding the trades made by Bertolini Robert J
(Executive Vice Presi of Charles River Laboratories International, Inc. at the time of this reporting) see
the Securities and Exchange Commission (SEC) website.